Noxafil (Posaconazole)

Save 65% on brand and over 50% on generic Noxafil vs US prices.

Information about Noxafil (Posaconazole)

Noxafil (Posaconazole) is an antifungal medication used to prevent and treat fungal infections caused by Aspergillus and Candida species, among others. It is part of the azole class of antifungals, working by inhibiting the growth of fungal cell membranes. Noxafil is particularly used in immunocompromised patients, such as those with HIV/AIDS or those undergoing chemotherapy, who are at high risk for serious fungal infections.

Product Highlights

• Noxafil is used to prevent invasive Aspergillus and Candida infections in patients with a weakened immune system, such as those undergoing chemotherapy for leukemia or bone marrow transplant recipients.
• Noxafil is also used to treat certain types of fungal infections in immunocompromised individuals, including:
• A severe fungal infection caused by Aspergillus species.
• A fungal infection caused by Candida species, including esophageal candidiasis.
• In patients with HIV/AIDS, Noxafil may be used to prevent or treat fungal infections, particularly in those with CD4 counts lower than 100 cells/mm³.
• It is also indicated for treating and preventing mucormycosis, a rare but life-threatening infection caused by molds.

Key Ingredient

• Posaconazole

Key Benefits

• Noxafil is effective against a wide range of fungal infections, including both molds (e.g., Aspergillus, Mucor species) and yeasts (e.g., Candida species).
• It is particularly useful for immunocompromised patients, such as those undergoing chemotherapy or bone marrow transplants, to prevent potentially life-threatening fungal infections.
• Noxafil is often used when other antifungal therapies, like fluconazole or itraconazole, are not effective due to resistance or intolerance.
• Noxafil is generally well-tolerated and can be taken orally (tablets or suspension), offering a non-invasive option for patients who may not be able to tolerate IV formulations.
• The use of Noxafil can significantly lower the incidence of severe, invasive fungal infections in at-risk populations, improving outcomes in immunocompromised individuals.

Directions for Use

Oral Tablets:

• For adults, the typical dose is 300 mg (2 tablets) on the first day, followed by 300 mg once daily.
• The tablets should be taken with food to improve absorption.

Oral Suspension:

• The usual dose for adults is 200 mg twice daily, or as directed by your healthcare provider.
• The suspension should be shaken well before use and taken with food for optimal absorption.

IV Infusion:

• For patients who cannot take oral medications, IV posaconazole may be administered in a healthcare setting.
• The IV dose is generally 300 mg on day 1, followed by 300 mg once daily for maintenance.
• Dosage may be adjusted in patients with liver impairment or those who are taking certain other medications that may interact with posaconazole.

Safety Concerns

• Liver function should be monitored during treatment. Noxafil can cause hepatotoxicity, including liver enzyme elevations. Discontinue treatment if significant liver toxicity is observed.
• Posaconazole can interact with other medications, including CYP3A4 inhibitors and inducers, which can affect its metabolism. Special care should be taken when used with drugs like anticonvulsants, antiretrovirals, and immunosuppressants.
• Noxafil may cause QT interval prolongation, which can lead to serious arrhythmias. It should be used with caution in patients with known cardiac arrhythmias or a history of QT prolongation.
• Common side effects may include nausea, vomiting, abdominal pain, and diarrhea. If gastrointestinal symptoms persist or worsen, contact your healthcare provider.
• Use caution in patients with renal impairment, as the drug may accumulate, increasing the risk of side effects.
• Noxafil should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Discuss with your doctor if you are pregnant or planning to become pregnant.

Avoid Noxafil (Posaconazole) If

• Do not use Noxafil if you have a known allergy to posaconazole, other azole antifungals, or any of its ingredients.
• Noxafil should be avoided in patients with severe hepatic impairment (liver failure) due to the risk of worsened liver toxicity.
• Avoid using Noxafil in patients who have congenital or acquired long QT syndrome, or those with a history of arrhythmias or a family history of sudden cardiac death.
• Noxafil should not be used with certain drugs, such as cisapride, pimozide, and ergot alkaloids, which can cause dangerous drug interactions.
• Noxafil should only be used during pregnancy if the potential benefits outweigh the risks. It is not known if Noxafil passes into breast milk, so it should be avoided during breastfeeding unless deemed essential by your healthcare provider.